+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases

The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases

Genetics in Medicine 9(8): 528-535

Purpose: Single genetic variants in multifactorial disorders typically have small effects, so major increases in disease risk are expected only from the simultaneous exposure to multiple risk genotypes. We investigated the impact of genotype frequencies on the clinical discriminative accuracy for the simultaneous testing of 40 independent susceptibility genetic variants. Methods: In separate simulation scenarios, we varied the genotype frequency from 1% to 50% and the odds ratio for each genetic variant from 1.1 to 2.0. Population size was 1 million and the population disease risk was 10%. Discriminative accuracy was quantified as the area under the receiver-operating characteristic curve. Using an example of genomic profiling for type 2 diabetes, we evaluated the area under the receiver-operating characteristic curve when the odds ratios and genotype frequencies varied between five postulated genetic variants. Results: When the genotype frequency was 1%, none of the subjects carried more than six of 40 risk genotypes, and when risk genotypes were frequent (>= 30%), all carried at least six. The area under the receiver-operating characteristic curve did not increase above 0.70 when the odds ratios were modest (1.1 or 1.25), but higher genotype frequency increased the area under the receiver-operating characteristic curve from 0.57 to 0.82 and from 0.63 to 0.93 when odds ratios were 1.5 or 2.0. The example of type 2 diabetes showed that the area under the receiver-operating characteristic curve did not change when differences in the odds ratios were ignored. Conclusions: Given that the effects of susceptibility genes in complex diseases are small, the feasibility of future genomic profiling for predicting common diseases will depend substantially on the frequencies of the risk genotypes.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 017400894

Download citation: RISBibTeXText

PMID: 17700391

DOI: 10.1097/gim.0b013e31812eece0

Related references

Predicting the impact of selection for scrapie resistance on PRNP genotype frequencies in goats. Veterinary Research 49(1): 26, 2018

Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia. Journal of Molecular Diagnostics 11(1): 25-34, 2009

Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proceedings of the National Academy of Sciences of the United States of America 101(4): 1039-1044, 2004

An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genetics in Medicine 6(1): 38-47, 2004

Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy. Bmc Cancer 17(1): 602, 2017

Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?. Journal of Inherited Metabolic Disease 24(Suppl. 2): 57-61; Discussion 45-6, 2001

Genomic Profiling of Chronic Myelogenous Leukemia: Basic and Clinical Approach. Journal of Cancer Prevention 22(2): 74-81, 2017

Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA 299(11): 1320-1334, 2008

Projected Clinical And Economic Impact Of Grazoprevir (Gzr, Mk-5172)/Elbasvir (Ebr, Mk-8742) For Chronic Hcv Genotype 1 Infection In Chronic Kidney Disease. Value in Health 18(7): A510, 2015

Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial. Genome Medicine 8(1): 109, 2016

Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers. Breast Cancer Research and Treatment 166(1): 179-184, 2017

The family burden in chronic diseases. The study of validity and reproducibility of the questionnaire on the impact of the chronic disease on the family (IMPAT). Minerva Psichiatrica 36(4): 171-178, 1995

High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 120(24): 4783-4794, 2012

Genomic profiling using array-based comparative genomic hybridization (aCGH) in chronic lymphocytic leukemia (CLL). 2008

Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin. Cold Spring Harbor Molecular Case Studies 4(2):, 2018